Comparative Trial of the Antiemetic Effects of THC and Haloperidol (scientific article published on 01 August 1981)

Q40080106	Advances in anti-emetic therapy
Q24644380	Adverse effects of medical cannabinoids: a systematic review
Q38598515	Cannabinoid Regulation of Acute and Anticipatory Nausea
Q24607823	Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review
Q24187798	Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy
Q43648938	Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB(1) receptors in the least shrew
Q46917530	Delta-9-tetrahydrocannabinol protects cardiac cells from hypoxia via CB2 receptor activation and nitric oxide production
Q34247474	Drugs related to tetrahydrocannabinol
Q40740167	Methodological issues in antiemetic studies
Q52096253	Nausea and vomiting as major complications of cancer chemotherapy.
Q45017344	Review of cannabinoids in the treatment of nausea and vomiting
Q24600806	The therapeutic potential of cannabis and cannabinoids
Q40133825	Treatment of nausea and vomiting caused by cancer chemotherapy
Q67274033	Use of nabilone in the treatment of chemotherapy-induced vomiting in an outpatient setting

P356	DOI	10.1002/J.1552-4604.1981.TB02571.X
P953	full work available at URL	http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1981.tb02571.x/fullpdf
		http://www.jclinpharm.org/cgi/content/abstract/21/8-9/38S
		https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fj.1552-4604.1981.tb02571.x
P698	PubMed publication ID	6271838